The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

If you take genes from another kind of plant, or bacteria, and insert them into a crop like soybeans, the result is considered a GMO. You need government approval to sell a new GMO. If you just take a snippet out of a gene without inserting anything new, though, the product falls into a gray area

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

The agency ruled that Dengvaxia, can only be used in individuals aged 9 to 16 living in parts of the United States where the dengue virus is endemic. Furthermore, the vaccine can only be given to children and teens who have had one previous laboratory-confirmed case of dengue

Quick Read

How an obsolete medical device with a security flaw became a must-have for some patients with type 1 diabetes. In 2014, a few hackers realized that the security flaw in certain Medtronic pumps could be exploited for a DIY revolution.

Quick Read

Overprescribed

April 3, 2019

High cost isn’t America’s only drug problem. The pharmaceutical industry has followed a brilliant two-pronged strategy to maximize its profits: raise prices and increase consumption of medications

Quick Read

Our Yoram Unguru writes, “Having cancer is hard enough without unnecessary and preventable impediments such as drug shortages, which represent a particularly vexing challenge. In the United States, shortages of drugs for cancer and other diseases over the past decade have become the new normal and the problem is getting worse.”

Quick Read

The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, which leave doctors and medical sleuths in the dark

Quick Read